Invention Grant
- Patent Title: Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferases
-
Application No.: US16290675Application Date: 2019-03-01
-
Publication No.: US11028083B2Publication Date: 2021-06-08
- Inventor: Maria Emilia Di Francesco , Philip Jones , Timothy Joseph McAfoos
- Applicant: Board of Regents, The University of Texas System
- Applicant Address: US TX Austin
- Assignee: Board of Regents, The University of Texas System
- Current Assignee: Board of Regents, The University of Texas System
- Current Assignee Address: US TX Austin
- Agent Dennis A. Bennett; Cynthia Hathaway; John Desper
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D498/04 ; A61P35/02 ; A61P3/00 ; C07D487/04 ; A61K45/06
Abstract:
The present invention relates to ethanediamine-heterocycle compounds that are able to act as inhibitors of PRMTs (protein arginine methyltransferases) for treating cancer and other diseases mediated by PRMTs.
Public/Granted literature
- US20190270739A1 ETHANEDIAMINE-HETEROCYCLE DERIVATIVES AS INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASES Public/Granted day:2019-09-05
Information query
